According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “
Other analysts have also issued reports about the stock. B. Riley started coverage on shares of Senseonics Holdings in a research report on Monday, September 26th. They issued a buy rating and a $5.50 price objective on the stock. Canaccord Genuity reissued a buy rating and issued a $6.00 price objective on shares of Senseonics Holdings in a research report on Wednesday, August 10th. Finally, Leerink Swann reissued an outperform rating and issued a $6.00 price objective (up from $4.50) on shares of Senseonics Holdings in a research report on Thursday, September 22nd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of Buy and a consensus target price of $5.25.
Senseonics Holdings (NYSEMKT:SENS) opened at 3.21 on Wednesday. Senseonics Holdings has a one year low of $2.53 and a one year high of $4.24. The company’s market capitalization is $299.78 million. The firm’s 50-day moving average price is $3.86 and its 200 day moving average price is $3.61.
Senseonics Holdings (NYSEMKT:SENS) last announced its earnings results on Tuesday, August 9th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.02. On average, equities research analysts expect that Senseonics Holdings will post ($0.49) earnings per share for the current fiscal year.
A number of institutional investors have recently modified their holdings of the company. Spark Investment Management LLC increased its position in Senseonics Holdings by 72.5% in the second quarter. Spark Investment Management LLC now owns 67,800 shares of the company’s stock worth $266,000 after buying an additional 28,500 shares in the last quarter. Abingworth LLP acquired a new position in Senseonics Holdings during the second quarter worth about $2,026,000. Teachers Advisors Inc. acquired a new position in Senseonics Holdings during the second quarter worth about $175,000. BlackRock Institutional Trust Company N.A. acquired a new position in Senseonics Holdings during the second quarter worth about $731,000. Finally, BlackRock Fund Advisors acquired a new position in Senseonics Holdings during the second quarter worth about $2,812,000.
Senseonics Holdings Company Profile
Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.